Temozolomide is an oral alkylating chemotherapy agent belonging to the imidazotetrazine class, primarily used for the treatment of glioblastoma multiforme and anaplastic astrocytoma. To support rigorous… Read more
![Chemical structure of (1H-Imidazole-4-carboxamide,5-amino-2-[2-[4-(aminocarbonyl)-1H-imidazol-5-yl]diazenyl]-)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F87614-68-4-1H-Imidazole-4-carboxamide5-amino-2-2-4-aminocarbonyl-1H-imidazol-5-yldiazenyl.png&w=3840&q=75)
![Chemical structure of 1,4-Dihydro-3-nitro-4-oxoimidazo[5,1-c][1,2,4]triazine-8-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F287964-59-4-14-Dihydro-3-nitro-4-oxoimidazo51-c124triazine-8-carboxamide.png&w=3840&q=75)














































Temozolomide is an oral alkylating chemotherapy agent belonging to the imidazotetrazine class, primarily used for the treatment of glioblastoma multiforme and anaplastic astrocytoma. To support rigorous pharmaceutical analysis, this category provides a comprehensive selection of Temozolomide reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and degradation products. Laboratories utilize these compounds for essential impurity profiling, enabling the characterization of structurally related analogs and degradation species formed through hydrolysis or oxidation. By employing these high-quality standards, researchers can ensure compliance with regulatory requirements during method validation and quality control processes. Additionally, the inclusion of stable isotope labelled compounds facilitates accurate quantification and complex analytical testing. These resources are critical for maintaining the potency, stability, and safety of pharmaceutical formulations, providing the precise tools necessary for reliable drug development and rigorous quality assurance in oncological research.